Last Updated:
Name Designation Appointment Date Status
Ahuti Rautaray

Appointed as Managing Director since November 2010

Managing Director 04-Nov-2010 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Susanta Senapati

Appointed as Director since December 2020

Director 14-Dec-2020 Current

People Timeline

Explore the timeline of key personnel in Seranti Pharmaceuticals Private Limited's leadership journey.

Loading...
Contact Details
  • Address 3-3-66/Fc Surya Selter-I, Infront Of Bolaram Stati Risala Bazar Burtonguda, Secunderabad Telangana, 500010, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 500010
  • Country India
  • Website -
Frequently Asked Questions
How can I contact Seranti Pharmaceuticals Private Limited?
You can contact Seranti Pharmaceuticals Private Limited through their registered address at 3-3-66/Fc Surya Selter-I, Infront Of Bolaram Stati Risala Bazar Burtonguda, Secunderabad Telangana, 500010, India, or via their website if available. Social media links are also provided where applicable.
Who are the current directors of Seranti Pharmaceuticals Private Limited?
The current directors of Seranti Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • AHUTI RAUTARAY
  • SUSANTA SENAPATI
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available